Situation normale

EPIONE PHARMACEUTICALS
 SRL

7500 Tournai
Since 17/03/2023
BE0799662258
Financial Health Indicator
7
Equity
€28.6K
Gross Operating Margin
€41.5K
EBITDA
€41.5K
Gain/Loss
€26.6K

EPIONE PHARMACEUTICALS’s business network visualized

Explore our interactive spiderweb to visually navigate EPIONE PHARMACEUTICALS’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb EPIONE PHARMACEUTICALS
EPIONE PHARMACEUTICALS
  • Alain HERNOÉ
    7500 Tournai

Detailed insights into EPIONE PHARMACEUTICALS’s financial history

See financial trends including, equity, operating income, profit/loss and employees of EPIONE PHARMACEUTICALS. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023
Equity
28.6K
Gross Operating Margin
41.5K
Gain/Loss
26.6K

Frequently asked questions about EPIONE PHARMACEUTICALS

  • What is the email adress of EPIONE PHARMACEUTICALS?

    You can contact EPIONE PHARMACEUTICALS at the email address alain.hernoe@gmail.com.
  • Where is EPIONE PHARMACEUTICALS located?

    EPIONE PHARMACEUTICALS’s headquarters is located in Rue As-Pois 6 1, 7500 Tournai.
  • Who are the directors of EPIONE PHARMACEUTICALS?

    EPIONE PHARMACEUTICALS’s directors include
    • Alain HERNOÉ
  • When was EPIONE PHARMACEUTICALS founded?

    EPIONE PHARMACEUTICALS was founded in 2023-03-17. EPIONE PHARMACEUTICALS has been active for 2 years.
  • What are EPIONE PHARMACEUTICALS’s NACEBEL codes?

    EPIONE PHARMACEUTICALS’s NACEBEL codes are
    • 46150 Intermédiaires du commerce en meubles, articles de ménage et quincaillerie (2008)
  • What is EPIONE PHARMACEUTICALS’s VAT number?

    EPIONE PHARMACEUTICALS’s VAT number is BE0799662258.
  • What is EPIONE PHARMACEUTICALS’s juridical form?

    EPIONE PHARMACEUTICALS’s juridical type is Société à responsabilité limitée (SRL).
  • How is the financial situation of EPIONE PHARMACEUTICALS?

    openthebox has estimated that EPIONE PHARMACEUTICALS’s financial health score to be 7/10.